BARDA awards 3 firms $72 million for bird flu vaccines
The US Biomedical Advanced Research and Development Authority (BARDA) is providing $72 million in grants to shore up its flu vaccine supply. The vaccines are aimed at influenza A(H5), which is responsible for the current outbreak of avian flu in dairy cows and a handful of humans. CSL Seqirus, Sanofi, and GSK will use the funds to fill and finish extra doses of their existing H5 vaccines from bulk storage into vials or prefilled syringes. They will also make additional flu antigen so that the shots will be ready to be deployed in an emergency.
Authors
- Rowan Walrath
Publication Details
- Journal
- C&EN Global Enterprise
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1021/cen-10232-buscon17
- Primary Topic
- Biotechnology and Related Fields
- Type
- article
- Field-Weighted Citation Impact
- 0.00